Efficacy and safety of pravastatin in the treatment of patients with type I or type II diabetes mellitus and hypercholesterolemia

Philip Raskin; Om P. Ganda; Sherwyn Schwartz; David Willard; Julio Rosenstock; Peter A. Lodewick; Michael D. Cressman; Beverly Phillipson; Bonnie Weiner; Mark E. McGovern; Jean M. Norton; Gabriella G. Cucinotta; Bruce D. Behounek

doi:10.1016/S0002-9343(99)80182-X

Efficacy and safety of pravastatin in the treatment of patients with type I or type II diabetes mellitus and hypercholesterolemia

Philip Raskin, Om P. Ganda, Sherwyn Schwartz, David Willard, Julio Rosenstock, Peter A. Lodewick, Michael D. Cressman, Beverly Phillipson, Bonnie Weiner, Mark E. McGovern, Jean M. Norton, Gabriella G. Cucinotta, Bruce D. Behounek

Research output: Contribution to journal › Article › peer-review

23 Scopus citations

Original language	English (US)
Pages (from-to)	362-369
Number of pages	8
Journal	The American Journal of Medicine
Volume	99
Issue number	4
DOIs	https://doi.org/10.1016/S0002-9343(99)80182-X
State	Published - Oct 1995

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1016/S0002-9343(99)80182-X

Cite this

Raskin, P., Ganda, O. P., Schwartz, S., Willard, D., Rosenstock, J., Lodewick, P. A., Cressman, M. D., Phillipson, B., Weiner, B., McGovern, M. E., Norton, J. M., Cucinotta, G. G., & Behounek, B. D. (1995). Efficacy and safety of pravastatin in the treatment of patients with type I or type II diabetes mellitus and hypercholesterolemia. The American Journal of Medicine, 99(4), 362-369. https://doi.org/10.1016/S0002-9343(99)80182-X

Raskin, P, Ganda, OP, Schwartz, S, Willard, D, Rosenstock, J, Lodewick, PA, Cressman, MD, Phillipson, B, Weiner, B, McGovern, ME, Norton, JM, Cucinotta, GG & Behounek, BD 1995, 'Efficacy and safety of pravastatin in the treatment of patients with type I or type II diabetes mellitus and hypercholesterolemia', The American Journal of Medicine, vol. 99, no. 4, pp. 362-369. https://doi.org/10.1016/S0002-9343(99)80182-X

@article{90dbd43f34c24af1953ccab067c09fd2,

title = "Efficacy and safety of pravastatin in the treatment of patients with type I or type II diabetes mellitus and hypercholesterolemia",

author = "Philip Raskin and Ganda, {Om P.} and Sherwyn Schwartz and David Willard and Julio Rosenstock and Lodewick, {Peter A.} and Cressman, {Michael D.} and Beverly Phillipson and Bonnie Weiner and McGovern, {Mark E.} and Norton, {Jean M.} and Cucinotta, {Gabriella G.} and Behounek, {Bruce D.}",

note = "Funding Information: From the Department of Internal Medicine (PR), University of Texas Health Science Center, Dallas, Texas; The Joslin Diabetes Center (OPG), Boston, Massachusetts; Diabetes and Glandular Disease Clinic 6% San Antonio, Texas: Princeton Medical Center (DW), Princeton, New Jersey: Dallas Diabetes and Endocrine Center (JR), Dallas, Texas; Larchmont Medical Center (PAL), Mt. Laurel, New Jersey; Research Division, Cleveland Clinic (MDC), Cleveland, Ohio; Providence Hospital (BP), Portland, Oregon; Division of Cardiovascular Medicine (BW), University of Massachusetts School of Medicine, Worcester, Massachusetts; and BristoCMyers Squibb Pharmaceutical Research Institute (MEM, JMN, GGC, BDB), Princeton, New Jersey. This study was supported by a grant from the Bristol-Myers Squibb Company, Princeton, New Jersey. Requests for reprints should be addressed to Bruce 0. Behounek, MD, Bristol-Myers Squibb Pharmaceutical Research Institute J2403, P.O. Box 4000, Princeton, New Jersey 085434000. Manuscript submitted August 12, 1994 and accepted in revised form January 11, 1995.",

year = "1995",

month = oct,

doi = "10.1016/S0002-9343(99)80182-X",

language = "English (US)",

volume = "99",

pages = "362--369",

journal = "The American Journal of Medicine",

issn = "0002-9343",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - Efficacy and safety of pravastatin in the treatment of patients with type I or type II diabetes mellitus and hypercholesterolemia

AU - Raskin, Philip

AU - Ganda, Om P.

AU - Schwartz, Sherwyn

AU - Willard, David

AU - Rosenstock, Julio

AU - Lodewick, Peter A.

AU - Cressman, Michael D.

AU - Phillipson, Beverly

AU - Weiner, Bonnie

AU - McGovern, Mark E.

AU - Norton, Jean M.

AU - Cucinotta, Gabriella G.

AU - Behounek, Bruce D.

N1 - Funding Information: From the Department of Internal Medicine (PR), University of Texas Health Science Center, Dallas, Texas; The Joslin Diabetes Center (OPG), Boston, Massachusetts; Diabetes and Glandular Disease Clinic 6% San Antonio, Texas: Princeton Medical Center (DW), Princeton, New Jersey: Dallas Diabetes and Endocrine Center (JR), Dallas, Texas; Larchmont Medical Center (PAL), Mt. Laurel, New Jersey; Research Division, Cleveland Clinic (MDC), Cleveland, Ohio; Providence Hospital (BP), Portland, Oregon; Division of Cardiovascular Medicine (BW), University of Massachusetts School of Medicine, Worcester, Massachusetts; and BristoCMyers Squibb Pharmaceutical Research Institute (MEM, JMN, GGC, BDB), Princeton, New Jersey. This study was supported by a grant from the Bristol-Myers Squibb Company, Princeton, New Jersey. Requests for reprints should be addressed to Bruce 0. Behounek, MD, Bristol-Myers Squibb Pharmaceutical Research Institute J2403, P.O. Box 4000, Princeton, New Jersey 085434000. Manuscript submitted August 12, 1994 and accepted in revised form January 11, 1995.

PY - 1995/10

Y1 - 1995/10

UR - http://www.scopus.com/inward/record.url?scp=0029112532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029112532&partnerID=8YFLogxK

U2 - 10.1016/S0002-9343(99)80182-X

DO - 10.1016/S0002-9343(99)80182-X

M3 - Article

C2 - 7573090

AN - SCOPUS:0029112532

SN - 0002-9343

VL - 99

SP - 362

EP - 369

JO - The American Journal of Medicine

JF - The American Journal of Medicine

IS - 4

ER -

Efficacy and safety of pravastatin in the treatment of patients with type I or type II diabetes mellitus and hypercholesterolemia

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this